Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy

Abstract Cancer is one of the most common diseases and causes of death worldwide. Since common treatment approaches do not yield acceptable results in many patients, developing innovative strategies for effective treatment is necessary. Immunotherapy is one of the promising approaches that has been...

Full description

Bibliographic Details
Main Authors: Mehregan Babamohamadi, Nastaran Mohammadi, Elham Faryadi, Maryam Haddadi, Amirhossein Merati, Farbod Ghobadinezhad, Roshanak Amirian, Zhila Izadi, Jamshid Hadjati
Format: Article
Language:English
Published: Nature Publishing Group 2024-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06391-x